Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Kolon TissueGene (950160 KS)
Watchlist
16
Analysis
Health Care
•
United States
Kolon TissueGene, Inc. operates as a biopharmaceutical company. The Company develops novel advanced orthopedic disorders cell therapies, novel cell and gene therapies drugs, and other related products. Kolon TissueGene offers services worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
CJ ENM
•
10 Nov 2017 22:06
CJ E&M Vs. Hanjin Kal - Trade Pattern Analysis Amid Subsidiary IPO
We, Korea, have two major IPOs coming up late this year. They are Studio Dragon Corp (253450 KS) and Jin Air Co., Ltd. (272450 KS). Both are...
Sanghyun Park
Follow
514 Views
Share
bullish
•
Kolon TissueGene
•
07 Nov 2017 02:29
TissueGene IPO Part 5 - Recap on First Day Trade
TissueGene Inc. (950160 KS)'s opening price was set at ₩52,000. Well, this is a whopping 92.6% up from the IPO price of ₩27,000. Eventually, it...
Sanghyun Park
Follow
399 Views
Share
bullish
•
Kolon TissueGene
•
19 Oct 2017 22:51
TissueGene IPO Part 4 - Bookbuilding Result Review
Can you believe this?TissueGene Inc. (950160 KS) IPO price was set at ₩27,000. This is the upper end of the indicative price band, ₩16,000 -...
Sanghyun Park
Follow
376 Views
Share
bullish
•
Kolon TissueGene
•
17 Oct 2017 13:38
TissueGene IPO Part 3 - More Fact Gathering from Yesterday's Press Meeting
It is time to decide on TissueGene Inc. (950160 KS) IPO. Its bookbuilding is actually taking place today and tomorrow. I know this is a very...
Sanghyun Park
Follow
608 Views
Share
bullish
•
Kolon TissueGene
•
02 Oct 2017 16:28
TissueGene IPO Part 2 - Facts About Cartilage Regeneration & US Clinical Trial
TissueGene Inc. (950160 KS) is 'still' clearly saying that its Invossa (TG-C) has the following three significant features. Requires only a single...
Sanghyun Park
Follow
528 Views
Share
First
Previous
1
2
3
4
Next
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x